These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25697718)

  • 1. Escaping the Hemoglobin A1c-Centric World in Evaluating Diabetes Mellitus Interventions.
    Vigersky RA
    J Diabetes Sci Technol; 2015 Feb; 9(5):1148-51. PubMed ID: 25697718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Comprehensive Glucose Pentagon: A Glucose-Centric Composite Metric for Assessing Glycemic Control in Persons With Diabetes.
    Vigersky RA; Shin J; Jiang B; Siegmund T; McMahon C; Thomas A
    J Diabetes Sci Technol; 2018 Jan; 12(1):114-123. PubMed ID: 28748705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
    Meneghini LF; Traylor L; Schwartz SL
    Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
    Ushigome E; Matsusaki S; Watanabe N; Hashimoto T; Nakamura N; Fukui M
    J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
    Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
    Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
    Vigersky RA; McMahon C
    Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of short-term professional continuous glucose monitoring in clinical practice.
    Leinung M; Nardacci E; Patel N; Bettadahalli S; Paika K; Thompson S
    Diabetes Technol Ther; 2013 Sep; 15(9):744-7. PubMed ID: 23786229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
    Rodbard HW; Jellinger PS; Davidson JA; Einhorn D; Garber AJ; Grunberger G; Handelsman Y; Horton ES; Lebovitz H; Levy P; Moghissi ES; Schwartz SS
    Endocr Pract; 2009; 15(6):540-59. PubMed ID: 19858063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.
    Anjana RM; Kesavadev J; Neeta D; Tiwaskar M; Pradeepa R; Jebarani S; Thangamani S; Sastry NG; Brijendra Kumar S; Ramu M; Gupta PPK; Vignesh J; Chandru S; Kayalvizhi S; Jagdish PS; Uthra SCB; Lovelena M; Jyoti S; Suguna Priya S; Kannan A; Mohan V; Unnikrishnan R
    Diabetes Technol Ther; 2017 Sep; 19(9):533-540. PubMed ID: 28930495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liberating A1C goals in older adults may not protect against the risk of hypoglycemia.
    Munshi MN; Slyne C; Segal AR; Saul N; Lyons C; Weinger K
    J Diabetes Complications; 2017 Jul; 31(7):1197-1199. PubMed ID: 28343792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
    Kennedy L; Herman WH; Strange P; Harris A;
    Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation.
    Kesavadev J; Vigersky R; Shin J; Pillai PBS; Shankar A; Sanal G; Krishnan G; Jothydev S
    Adv Ther; 2017 Aug; 34(8):1918-1927. PubMed ID: 28667580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes mellitus: managing hemoglobin A(1c) and beyond.
    Fowler GC; Vasudevan DA
    South Med J; 2010 Sep; 103(9):911-6. PubMed ID: 20689486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of Internet intervention on 926 patients with diabetes mellitus for up to 30 months.
    Tildesley HD; Conway ME; Deng L; Lee AM; Chan JH; Mazanderani AB; Tildesley HG; White AS; Pawlowska M; Ross SA
    Can J Diabetes; 2015 Jun; 39(3):216-20. PubMed ID: 25623618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes duration and the efficacy and safety of insulin glargine versus comparator treatment in patients with type 2 diabetes mellitus.
    Garg SK; Aurand LA; Rimler MS; Dailey GE
    Endocr Pract; 2014 Feb; 20(2):120-8. PubMed ID: 24013981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Insulin Therapy: Basal Insulin and Beyond.
    Aroda V; Johnson EL; Novak L; Skolnik N
    J Fam Pract; 2018 Oct; 67(10 Suppl):. PubMed ID: 30423012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
    Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
    Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency and Predictors of Self-Reported Hypoglycemia in Insulin-Treated Diabetes.
    Malkani S; Kotwal A
    J Diabetes Res; 2017; 2017():7425925. PubMed ID: 28913365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.